Dov Elefant
Equibles does not estimate personal net worth.
Get an email with a short summary when Femasys Inc publishes a filing, an earnings call transcript or a press release.
Get FEMY alertsAbout Dov Elefant
Dov Elefant is recorded as CFO at Femasys Inc (FEMY). The newest filing on record that lists Dov Elefant as CFO at Femasys Inc (FEMY) is dated April 30, 2026. Earlier roles on record: CFO at Cellectar Biosciences, Inc. (CLRB) until February 22, 2022. Cellectar Biosciences, Inc. reported in an 8-K filed February 25, 2022 that Dov Elefant resigned as Chief Financial Officer, effective February 22, 2022. Femasys Inc reported in an 8-K filed February 24, 2022 that Dov Elefant was appointed Chief Financial Officer, effective February 28, 2022. The proxy statement of Cellectar Biosciences, Inc. reports total compensation of $838,150 for Dov Elefant in fiscal 2021, including a base salary of $356,895. Disclosed compensation is on record for 3 fiscal years. Femasys Inc is classified in the Medical Instruments & Supplies industry within the Healthcare sector. Other leadership on record at Femasys Inc includes Kathy Lee-Sepsick (CEO and Board Member), Daniel Currie (COO), John Canning (COO) and 7 others.
“On February 22, 2022, Dov Elefant, the Chief Financial Officer of Cellectar Biosciences, Inc. (the “Company”), resigned from his office effective February 22, 2022.”
“On February 24, 2022, Femasys Inc. (the “Company”) announced the hiring and appointment of Dov Elefant as its Chief Financial Officer, effective February 28, 2022.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 30, 2026
-
Start not stated–2022-02-22
Company network
Leadership on record at Femasys Inc
- Kathy Lee-Sepsick CEO, Board Member
- Daniel Currie COO
- John Canning COO
- Jeremy Sipos CTO
- Alistair Milnes Board Member
- Charles Larsen Board Member
- Edward Uzialko Board Member
- John Moorhead Board Member
- Joshua Silverman Board Member
- Keith J. Kendall Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Cellectar Biosciences, Inc. (CLRB) | Former Vice President and Chief Financial Officer | $356,895 | $838,150 |
| 2020 | Cellectar Biosciences, Inc. (CLRB) | Former Vice President and Chief Financial Officer | $324,450 | $471,860 |
| 2019 | Cellectar Biosciences, Inc. (CLRB) | Vice President and Chief Financial Officer | $97,500 | $312,437 |